Evoke Pharma Balance Sheet - Quarterly (NASDAQ:EVOK)

Add to My Stocks
$3.18 $0.02 (0.63%) EVOK stock closing price Sep 21, 2018 (Closing)

A thorough fundamental analysis involves using data from Evoke Pharma balance sheet, apart from other financial statements, to value the business. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Evoke Pharma stock analysis. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Evoke Pharma balance sheet as at the end of 2018 Q2 indicates an asset turnover ratio of and debt to equity ratio of . Also check Evoke Pharma revenue and Evoke Pharma operating cash flow for the same period.

View and download Evoke Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets----------
Total Current Assets
Property Plant & Equipment----------
Accumulated Depreciation----------
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable--1.04M1.72M1.12M---1.26M1.24M
Current Portion Long-Term Debt--------4.39M-
Current Portion Capital Leases----------
Accrued Expenses--1.02M-------
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt---------3.68M
Non-Current Capital Leases----------
Other Long-Term Liabilities--3.7M6.05M4.5M5.76M4.09M5.09M--
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus80.68M77.4M73.2M72.78M72.25M71.79M62.59M61.98M52.72M52.04M
Retained Earnings-75.32M-73.02M-71.03M-70.73M-65.48M-63.86M-58.8M-57.28M-54.25M-51.28M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity5.36M4.38M2.16M2.05M6.76M7.93M3.78M4.7M-1.52M-
Total Liabilities & Shareholders Equity6.62M5.58M7.94M10.75M13.15M14.83M9.29M10.81M4.63M6.87M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Evoke Pharma historical stock prices and the current Evoke Pharma stock price can tell you how the stock price has moved, whereas the Evoke Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Evoke Pharma owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for EVOK stock as of 2018 Q2 is $6.62M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of Evoke Pharma for the quarter 2018 Q2 total to $1.26M. Liabilities for a company like Evoke Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Evoke Pharma Balance Sheet - Key Ratios